CFMC
AZN icon

Curbstone Financial Management Corp’s AstraZeneca AZN Stock Holding History

Curbstone Financial Management Corp’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$427K Hold
2,252
– – 0.07% 205
2026
Q1 		$444K Sell
2,252
-4
-0.2% -$771 0.09% 188
2025
Q4 		$415K Buy
+2,256
New +$396K 0.08% 192

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Curbstone Financial Management Corp's AZN Position: Q2 2026 in Review

Curbstone Financial Management Corp held its AstraZeneca (AZN) position steady in Q2 2026 at 2,252 shares worth $427K. The position accounts for 0.07% of the portfolio, ranked #205.

Curbstone Financial Management Corp first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $444K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Curbstone Financial Management Corp held 2,252 shares of AstraZeneca worth $427K as of Q2 2026.
  • Curbstone Financial Management Corp left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.07% of Curbstone Financial Management Corp's portfolio in Q2 2026, its #205 holding.
  • Curbstone Financial Management Corp first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
  • Curbstone Financial Management Corp's AstraZeneca position peaked at $444K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Curbstone Financial Management Corp's 13F filing for Q2 2026, filed 14 Jul 2026.